IT1284852B1 - Uso dell'interferone alfa naturale umano da cellule leucocitarie per la terapia delle epatiti virali, neoplasie e sindromi da - Google Patents

Uso dell'interferone alfa naturale umano da cellule leucocitarie per la terapia delle epatiti virali, neoplasie e sindromi da

Info

Publication number
IT1284852B1
IT1284852B1 ITRM960427A IT1284852B1 IT 1284852 B1 IT1284852 B1 IT 1284852B1 IT RM960427 A ITRM960427 A IT RM960427A IT 1284852 B1 IT1284852 B1 IT 1284852B1
Authority
IT
Italy
Prior art keywords
interferon
natural human
human alpha
neoplasia
preparation
Prior art date
Application number
Other languages
English (en)
Inventor
Renzo Brozzo
Giulio Tarro
Original Assignee
Ist Farmacoterapico It Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Farmacoterapico It Spa filed Critical Ist Farmacoterapico It Spa
Publication of ITRM960427A0 publication Critical patent/ITRM960427A0/it
Priority to IT96RM000427 priority Critical patent/IT1284852B1/it
Priority to PCT/IT1997/000040 priority patent/WO1997031649A1/en
Priority to ES97905395T priority patent/ES2160927T3/es
Priority to PT97905395T priority patent/PT886527E/pt
Priority to EP97905395A priority patent/EP0886527B1/en
Priority to GEAP19974506A priority patent/GEP20012489B/en
Priority to KR10-1998-0706297A priority patent/KR100394382B1/ko
Priority to AT97905395T priority patent/ATE205397T1/de
Priority to US09/125,122 priority patent/US6884411B1/en
Priority to AU22299/97A priority patent/AU722987B2/en
Priority to DK97905395T priority patent/DK0886527T3/da
Priority to EA199800770A priority patent/EA001147B1/ru
Priority to DE69706657T priority patent/DE69706657T2/de
Priority to BR9707772-0A priority patent/BR9707772A/pt
Priority to JP9530771A priority patent/JP2000506839A/ja
Publication of ITRM960427A1 publication Critical patent/ITRM960427A1/it
Application granted granted Critical
Publication of IT1284852B1 publication Critical patent/IT1284852B1/it

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT96RM000427 1996-02-28 1996-06-14 Uso dell'interferone alfa naturale umano da cellule leucocitarie per la terapia delle epatiti virali, neoplasie e sindromi da IT1284852B1 (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT96RM000427 IT1284852B1 (it) 1996-06-14 1996-06-14 Uso dell'interferone alfa naturale umano da cellule leucocitarie per la terapia delle epatiti virali, neoplasie e sindromi da
US09/125,122 US6884411B1 (en) 1996-02-28 1997-02-27 Method of treating viral hepatitis by administration of liquid human α-interferon
DK97905395T DK0886527T3 (da) 1996-02-28 1997-02-27 Farmaceutiske sammensætninger indeholdende naturligt humant alfa-interferon
PT97905395T PT886527E (pt) 1996-02-28 1997-02-27 Composicao farmaceutica que incorpora o interferao alfa humano natural
EP97905395A EP0886527B1 (en) 1996-02-28 1997-02-27 Pharmaceutical compositions comprising natural human alpha-interferon
GEAP19974506A GEP20012489B (en) 1996-02-28 1997-02-27 Use of Natural Human α-Interferon
KR10-1998-0706297A KR100394382B1 (ko) 1996-02-28 1997-02-27 천연사람α-인터페론으로구성된약학조성물
AT97905395T ATE205397T1 (de) 1996-02-28 1997-02-27 Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen
PCT/IT1997/000040 WO1997031649A1 (en) 1996-02-28 1997-02-27 PHARMACEUTICAL COMPOSITIONS COMPRISING NATURAL HUMAN α-INTERFERON
AU22299/97A AU722987B2 (en) 1996-02-28 1997-02-27 Pharmaceutical compositions comprising natural human alpha-interferon
ES97905395T ES2160927T3 (es) 1996-02-28 1997-02-27 Composiciones farmaceuticas que comprenden interferon alfa humano natural.
EA199800770A EA001147B1 (ru) 1996-02-28 1997-02-27 Лекарственный препарат для терапевтического лечения вирусного гепатита
DE69706657T DE69706657T2 (de) 1996-02-28 1997-02-27 Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen
BR9707772-0A BR9707772A (pt) 1996-02-28 1997-02-27 Composições farmacêuticas compreendendo alfa-interferon humano natural
JP9530771A JP2000506839A (ja) 1996-02-28 1997-02-27 天然ヒトα―インターフェロンを含む薬剤組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000427 IT1284852B1 (it) 1996-06-14 1996-06-14 Uso dell'interferone alfa naturale umano da cellule leucocitarie per la terapia delle epatiti virali, neoplasie e sindromi da

Publications (3)

Publication Number Publication Date
ITRM960427A0 ITRM960427A0 (it) 1996-06-14
ITRM960427A1 ITRM960427A1 (it) 1997-12-14
IT1284852B1 true IT1284852B1 (it) 1998-05-22

Family

ID=11404287

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96RM000427 IT1284852B1 (it) 1996-02-28 1996-06-14 Uso dell'interferone alfa naturale umano da cellule leucocitarie per la terapia delle epatiti virali, neoplasie e sindromi da

Country Status (1)

Country Link
IT (1) IT1284852B1 (it)

Also Published As

Publication number Publication date
ITRM960427A0 (it) 1996-06-14
ITRM960427A1 (it) 1997-12-14

Similar Documents

Publication Publication Date Title
TW265265B (it)
KR890700035A (ko) 개량된 인터페론 요법
AU7589587A (en) Low dosage of interferon to enhance vaccine efficiency
IT1283945B1 (it) Uso dell'interferone alfa naturale umano da cellule linfoblastoidi per la terapia delle epatiti virali, neoplasie e sindromi da
ATE205397T1 (de) Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen
OA08768A (fr) Traitement du virus su SIDA par l'interféron alpha humain recombinant.
NZ284914A (en) use of anti-arthritogenic peptide antibodies, nonadsorbable antibiotic or benign bacteria to treat rheumatoid arthritis by enteral administration
HUP9902188A2 (hu) Természetes humán alfa-interferont tartalmazó gyógyszerkészítmények
MY111746A (en) Therapeutic nucleosides.
MY119359A (en) Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis.
DE3686536D1 (de) Oxytocin und antigestagen zur einleitung der geburt.
Sanders et al. Immune-associated toxicities induced by in vivo and in vitro exposure to interferon-alpha alone or in combination with nucleoside analogs
RU93041496A (ru) γ -РL/ГАММА-ПЛАНТ/-ИНТЕРФЕРОНИНДУЦИРУЮЩЕЕ СРЕДСТВО
DK374388A (da) Immunterapeutisk, oral interferondosisform samt fremgangsmaade til fremstilling heraf
RU92011195A (ru) Способ уменьшения дозы химиопрепаратов, используемых для лечения инфекционных заболеваний при одновременном повышении их терапевтической эффективности
RU96110267A (ru) Способ лечения острого вирусного гепатита b

Legal Events

Date Code Title Description
0001 Granted